These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 29706623)

  • 1. The deubiquitinase USP21 stabilizes MEK2 to promote tumor growth.
    Li W; Cui K; Prochownik EV; Li Y
    Cell Death Dis; 2018 May; 9(5):482. PubMed ID: 29706623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A.
    Xiong B; Huang J; Liu Y; Zou M; Zhao Z; Gong J; Wu X; Qiu C
    Cell Oncol (Dordr); 2021 Apr; 44(2):329-343. PubMed ID: 33074477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration.
    Chiu CY; Kuo KK; Kuo TL; Lee KT; Cheng KH
    Mol Cancer Res; 2012 Mar; 10(3):415-27. PubMed ID: 22241220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation.
    Hou P; Ma X; Zhang Q; Wu CJ; Liao W; Li J; Wang H; Zhao J; Zhou X; Guan C; Ackroyd J; Jiang S; Zhang J; Spring DJ; Wang YA; DePinho RA
    Genes Dev; 2019 Oct; 33(19-20):1361-1366. PubMed ID: 31488580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin-specific protease 4 promotes hepatocellular carcinoma progression via cyclophilin A stabilization and deubiquitination.
    Li T; Yan B; Ma Y; Weng J; Yang S; Zhao N; Wang X; Sun X
    Cell Death Dis; 2018 Feb; 9(2):148. PubMed ID: 29396555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
    Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1 Deubiquitination by USP21 Regulates Cell Cycle Progression and Paclitaxel Sensitivity in Basal-like Breast Cancer.
    Arceci A; Bonacci T; Wang X; Stewart K; Damrauer JS; Hoadley KA; Emanuele MJ
    Cell Rep; 2019 Mar; 26(11):3076-3086.e6. PubMed ID: 30865895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
    Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
    Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of Rab17 promotes tumourigenic properties of hepatocellular carcinoma cells via Erk pathway.
    Qi J; Zhao P; Li F; Guo Y; Cui H; Liu A; Mao H; Zhao Y; Zhang X
    Int J Clin Exp Pathol; 2015; 8(5):4963-71. PubMed ID: 26191189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways.
    Bao L; Yan Y; Xu C; Ji W; Shen S; Xu G; Zeng Y; Sun B; Qian H; Chen L; Wu M; Su C; Chen J
    Cancer Lett; 2013 Sep; 337(2):226-36. PubMed ID: 23684551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma.
    Lu C; Ning Z; Wang A; Chen D; Liu X; Xia T; Tekcham DS; Wang W; Li T; Liu X; Liu J; Qi H; Luo H; Du J; Ma C; Yan Q; Liu J; Xu G; Piao HL; Tan G
    Cancer Lett; 2018 Nov; 436():139-148. PubMed ID: 30056112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MECP2 promotes cell proliferation by activating ERK1/2 and inhibiting p38 activity in human hepatocellular carcinoma HEPG2 cells.
    Zhao LY; Zhang J; Guo B; Yang J; Han J; Zhao XG; Wang XF; Liu LY; Li ZF; Song TS; Huang C
    Cell Mol Biol (Noisy-le-grand); 2013 Nov; Suppl 59():OL1876-81. PubMed ID: 24199952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deubiquitination of the repressor E2F6 by USP22 facilitates AKT activation and tumor growth in hepatocellular carcinoma.
    Jing T; Wang B; Yang Z; Liu Y; Xu G; Xu X; Jiao K; Chen Z; Xiang L; Zhang L; Liu Y
    Cancer Lett; 2021 Oct; 518():266-277. PubMed ID: 34339800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma.
    Lu SX; Zhang CZ; Luo RZ; Wang CH; Liu LL; Fu J; Zhang L; Wang H; Xie D; Yun JP
    Cancer Lett; 2017 Aug; 402():71-80. PubMed ID: 28577975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USP16 Downregulation by Carboxyl-terminal Truncated HBx Promotes the Growth of Hepatocellular Carcinoma Cells.
    Qian Y; Wang B; Ma A; Zhang L; Xu G; Ding Q; Jing T; Wu L; Liu Y; Yang Z; Liu Y
    Sci Rep; 2016 Sep; 6():33039. PubMed ID: 27633997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
    Cheng J; Wu LM; Deng XS; Wu J; Lv Z; Zhao HF; Yang Z; Ni Y
    Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):336-344. PubMed ID: 30108016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitin-specific protease 21 stabilizes BRCA2 to control DNA repair and tumor growth.
    Liu J; Kruswick A; Dang H; Tran AD; Kwon SM; Wang XW; Oberdoerffer P
    Nat Commun; 2017 Jul; 8(1):137. PubMed ID: 28743957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP14 maintains HIF1-α stabilization via its deubiquitination activity in hepatocellular carcinoma.
    Lv C; Wang S; Lin L; Wang C; Zeng K; Meng Y; Sun G; Wei S; Liu Y; Zhao Y
    Cell Death Dis; 2021 Aug; 12(9):803. PubMed ID: 34420039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model.
    Chen JC; Chuang HY; Hsu FT; Chen YC; Chien YC; Hwang JJ
    Oncotarget; 2016 Dec; 7(51):85450-85463. PubMed ID: 27863427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD; Sun XJ; Yin JJ; Yin M; Wang W; Nie ZQ; Xu J
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.